A3 adenosine receptor ligand for use for achieving a fat loss effect

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12213990
APP PUB NO 20220079968A1
SERIAL NO

17309952

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is an A3 adenosine receptor (A3AR) ligand for use in achieving at least one fat loss effect selected from: reducing weight of the subject; reducing body fat mass in the subject; treating obesity in the subject and inhibiting adipocytes proliferation in a subject. The disclosure also concerns pharmaceutical compositions, methods of treatment and kits comprising the A3AR ligand.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CAN-FITE BIOPHARMA LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cohen, Shira Hod Hasharon, IL 8 8
Farbstein, Motti Petach Tikva, IL 1 0
Fishman, Pnina Herzliya, IL 43 131
Itzhak, Inbal Kfar Saba, IL 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 4, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 4, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 4, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00